EPISODE · Nov 1, 2018 · 9 MIN
CEO Eyal Barad of Cannabics Pharmaceuticals Inc. (OTCQB: CNBX)
from Stock Day Media · host Stock Day Media
CEO Eyal Barad of Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), joins the show to discuss cancer therapy using cannabinoids, developing patient specific therapies, and the future of the medical cannabis industry. OTCQB: CNBX # cannabinoid based cancer therapy # Israel # cancer patients # tumors # Anorexia # fully licensed # Liquid Biopsy # personalized diagnostic tools # practitioners and patients # tailored therapies Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
CEO Eyal Barad of Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), joins the show to discuss cancer therapy using cannabinoids, developing patient specific therapies, and the future of the medical cannabis industry. OTCQB: CNBX # cannabinoid based cancer therapy # Israel # cancer patients # tumors # Anorexia # fully licensed # Liquid Biopsy # personalized diagnostic tools # practitioners and patients # tailored therapies Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO Eyal Barad of Cannabics Pharmaceuticals Inc. (OTCQB: CNBX)
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m